UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2004-11, Vol.43 (11), p.1397-1405

2004

Volltextzugriff (PDF)

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Neuropsychopharmacology (New York, N.Y.), 2002-11, Vol.27 (5), p.699-711

2002

Volltextzugriff (PDF)

Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2002-10, Vol.41 (10), p.1205-1215

2002

Volltextzugriff (PDF)

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder

The journal of clinical psychiatry, 2002-12, Vol.63 (12), p.1140-1147

2002

Volltextzugriff (PDF)

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

Journal of clinical psychopharmacology, 2001-12, Vol.21 (6), p.561-568

2001

Volltextzugriff (PDF)

Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2002-07, Vol.41 (7), p.776-784

2002

Volltextzugriff (PDF)

Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder

Pediatrics (Evanston), 2002-12, Vol.110 (6), p.e75-e75

2002

Volltextzugriff (PDF)

The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration

Biological Psychiatry, 2004-07, Vol.56 (1), p.3-9

2004

Volltextzugriff (PDF)

Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study

Journal of child and adolescent psychopharmacology, 2006-02, Vol.16 (1-2), p.207

2006

Volltextzugriff (PDF)

Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

Journal of attention disorders, 2001-09, Vol.5 (2), p.107-115

2001

Volltextzugriff (PDF)

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents

Journal of child and adolescent psychopharmacology, 2004-09, Vol.14 (3), p.412-417

2004

Volltextzugriff (PDF)

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine

The journal of clinical psychiatry, 1998-02, Vol.59 (2), p.49-55

1998

Volltextzugriff (PDF)

Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

Journal of child and adolescent psychopharmacology, 2006-03, Vol.16 (1-2), p.207-217

2006

Volltextzugriff (PDF)

Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in major depression?

Neuropsychopharmacology (New York, N.Y.), 1996-01, Vol.14 (1), p.47-53

1996

Volltextzugriff (PDF)

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer

Psycho-oncology (Chichester, England), 1998-07, Vol.7 (4), p.291-300

1998

Volltextzugriff (PDF)

A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression

International psychogeriatrics, 1995-03, Vol.7 (1), p.89-104

1995

Volltextzugriff (PDF)

A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive Disorder

Journal of the American Statistical Association, 1994-09, Vol.89 (427), p.768-776

1994

Volltextzugriff (PDF)

Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis

Journal of affective disorders, 1998, Vol.47 (1), p.71-79

1998

Volltextzugriff (PDF)

SSRI Antidepressant Drug Use Patterns in the Naturalistic Setting: A Multivariate Analysis

Medical care, 1999-04, Vol.37 (4), p.AS36-AS44

1999

Volltextzugriff (PDF)

Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings

Journal of clinical psychopharmacology, 1993-10, Vol.13 (5), p.312-320

1993

Volltextzugriff (PDF)

Fluoxetine and Suicide: a Meta-analysis of Controlled Trials of Treatment for Depression

International clinical psychopharmacology, 1992-06, Vol.6 Suppl 6, p.35-57

1992

Volltextzugriff (PDF)

Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo

Journal of affective disorders, 1994-03, Vol.30 (3), p.163-173

1994

Volltextzugriff (PDF)

Acute Effects of Fluoxetine Versus Placebo on Functional Health and Well-Being in Late-Life Depression

International psychogeriatrics, 1995-10, Vol.7 (S1), p.125-137

1995

Volltextzugriff (PDF)

Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine

Journal of clinical psychopharmacology, 1994-12, Vol.14 (6), p.385-391

1994

Volltextzugriff (PDF)

Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients

Psychiatry research, 1994-06, Vol.52 (3), p.327-339

1994

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Female
(20)
Life Sciences & Biomedicine
(20)
Male
(20)
Science & Technology
(20)
Medical Sciences
(19)
Biological And Medical Sciences
(18)
Pharmacology. Drug Treatments
(15)
Psychiatry
(15)
Psychology. Psychoanalysis. Psychiatry
(15)
Psychopharmacology
(15)
Adolescent
(14)
Depressive Disorder - Drug Therapy
(14)
Double-Blind Method
(13)
Fluoxetine - Therapeutic Use
(13)
Neuropharmacology
(13)
Psychoanaleptics: Cns Stimulant, Antidepressant Agent, Nootropic Agent, Mood Stabilizer...,
(13)
Adult
(11)
Child
(11)
Fluoxetine - Adverse Effects
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial

Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial

Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder

The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration

Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study

Validation of the ADHD Rating Scale as a clirlician administered and scored instrument

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents

Should anxiety and insomnia influence antidepressant selection: a randomized comparison of fluoxetine and imipramine

Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study

Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in major depression?

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer

A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major Depression

A Case Study of an Adaptive Clinical Trial in the Treatment of Out-Patients with Depressive Disorder

Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis

SSRI Antidepressant Drug Use Patterns in the Naturalistic Setting: A Multivariate Analysis

Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings

Fluoxetine and Suicide: a Meta-analysis of Controlled Trials of Treatment for Depression

Response patterns of depressed outpatients with and without melancholia: a double-blind, placebo-controlled trial of fluoxetine versus placebo

Acute Effects of Fluoxetine Versus Placebo on Functional Health and Well-Being in Late-Life Depression

Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine

Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients

Suchergebnisse filtern